Macrophage activation marker soluble CD163 may predict disease progression in hepatocellular carcinoma.
Kazankov K, Rode A, Simonsen K, Villadsen GE, Nicoll A, Møller HJ, Lim L, Angus P, Kronborg I, Arachchi N, Gorelik A, Liew D, Vilstrup H, Frystyk J, Grønbæk H.
Kazankov K, et al.
Scand J Clin Lab Invest. 2016;76(1):64-73. doi: 10.3109/00365513.2015.1099722. Epub 2015 Nov 7.
Scand J Clin Lab Invest. 2016.
PMID: 26549495